Literature DB >> 6210473

Alterations of T-cell subsets in primary biliary cirrhosis.

A K Bhan, J L Dienstag, J R Wands, S F Schlossman, E L Reinherz.   

Abstract

To determine whether abnormalities of immunoregulatory T cells are associated with primary biliary cirrhosis, we characterized peripheral blood mononuclear cells in 16 patients with primary biliary cirrhosis and compared them with 30 normal controls. For this analysis we used monoclonal antibodies to the surface antigens on helper/inducer (T4+) and suppressor (T8+) T cell subsets and to a common T cell antigen (T3+). In contrast to normal persons, patients with primary biliary cirrhosis had reduced percentages of T3+ cells. More importantly, there was a relative decrease in helper/inducer (T4+) cells in 9/16 patients and a decrease in suppressor (T8+) cells in 5/16 patients. Furthermore, clinical studies indicated that patients with a decreased suppressor cell population (increased T4+ : T8+ ratio) had more advanced disease, as reflected by serum bilirubin levels (P less than 0.05) and histological changes in the liver (P less than 0.001), than those patients with a reduced helper T cell population (decreased T4+ : T8+ ratio). These data suggest that abnormalities of immune responsiveness in primary biliary cirrhosis may have a more complex origin than a uniform alteration in one immunoregulatory T-cell subset and that these immunoregulatory cell changes vary according to the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6210473      PMCID: PMC1536516     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

2.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis.

Authors:  H C Thomas; R Holden; J V Jones; D B Peacock
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

4.  Circulating immune complexes and complement activation in primary biliary cirrhosis.

Authors:  J R Wands; J L Dienstag; A K Bhan; E R Feller; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

5.  Rosette inhibition test in chronic liver disease.

Authors:  F Salerno; S R Fargion; M D Cappellini; G Fiorelli; N Dioguardi
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

6.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

7.  Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; R H Keller; W H Summerskill; E R Dickson; T B Tomasi; R G Shorter
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

8.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; C Funk; B Portmann; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

10.  Is primary biliary cirrhosis an immune complex disease?

Authors:  H C Thomas; B J Potter; S Sherlock
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

View more
  15 in total

1.  Lymphocyte subpopulations in patients with alcoholic liver disease.

Authors:  R Jovanovic; T Worner; C S Lieber; F Paronetto
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

Authors:  L Si; T L Whiteside; R R Schade; T E Starzl; D H Van Thiel
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

3.  T cell subpopulation dynamics following insulin-induced hypoglycaemia in normal subjects.

Authors:  H L Bhakri; H Jones; D A Jones; K W Pettingale; D E Tee
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

4.  The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis.

Authors:  H P Schultheiss; P Berg; M Klingenberg
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

5.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

6.  T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis.

Authors:  D H Van Thiel; K N Chen; M C Chien; V J Dindzans; J S Gavaler; T L Whiteside
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

7.  Primary biliary cirrhosis presenting with granulomatous skin lesions.

Authors:  D L Jardine; S T Chambers; D J Hart; B A Chapman
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.

Authors:  D Ilfeld; E Theodor; G Delpre; O Kuperman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

10.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.